Re: Second cancers after adjuvant tamoxifen therapy for breast cancer [3]

Journal of the National Cancer Institute

Volumn 88, Issue 20, 1996, Pages 1496-1499

  Atkins, C D ^a   Curtis, R E ^a   Boice J D , Jr ^a   Shriner, D A ^a   Hankey, B F ^a   Fraumeni J F , Jr ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER RISK; CLINICAL TRIAL; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; ENDOMETRIUM CANCER; HUMAN; LETTER; MAJOR CLINICAL STUDY; SECOND CANCER; STOMACH CANCER;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; ODDS RATIO; RISK; SEER PROGRAM; TAMOXIFEN;

EID: 0029796726     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.20.1496     Document Type: Letter

References (0)